InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

HALOZYME THERAPEUTICS, INC.

HALO Clue Score50
United States Fiscal year ends December CIK 0001159036 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

38
Insider
Date
Role
Action
Shares
Price
Amount
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
100
$110.04
$11.00K
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
1,100
$109.57
$120.53K
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
3,300
$108.45
$357.90K
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
730
$107.17
$78.23K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
4,000
$108.99
$435.96K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
8,896
$108.04
$961.12K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
3,000
$106.83
$320.48K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
3,100
$106.13
$329.01K
Bernadette Connaughton
10 Aug 2026
Director
Sold on a plan
1,626
$102.80
$167.15K
Bernadette Connaughton
1 Jul 2026
Director
Sold on a plan
625
$77.21
$48.26K
Bernadette Connaughton
1 Jul 2026
Director
Sold on a plan
1,000
$76.40
$76.40K
Bernadette Connaughton
1 Jun 2026
Director
Sold on a plan
1,625
$66.21
$107.59K
Bernadette Connaughton
1 May 2026
Director
Sold on a plan
1,625
$63.48
$103.16K
Bernadette Connaughton
5 Jan 2026
Director
Sold on a plan
2,000
$70.25
$140.50K
Bernadette Connaughton
1 Dec 2025
Director
Sold on a plan
829
$71.60
$59.36K
Bernadette Connaughton
10 Nov 2025
Director
Sold on a plan
2,000
$68.48
$136.96K
Bernadette Connaughton
1 Oct 2025
Director
Sold on a plan
500
$75.70
$37.85K
Bernadette Connaughton
1 Oct 2025
Director
Sold on a plan
1,500
$75.09
$112.63K
Nicole LaBrosse
22 Sep 2025
SVP, Chief Financial Officer
Sold on a plan
314
$78.67
$24.70K
Nicole LaBrosse
22 Sep 2025
SVP, Chief Financial Officer
Sold on a plan
1,913
$77.83
$148.88K
Bernadette Connaughton
2 Sep 2025
Director
Sold on a plan
923
$74.11
$68.40K
Bernadette Connaughton
2 Sep 2025
Director
Sold on a plan
2,977
$73.62
$219.16K
Bernadette Connaughton
2 Sep 2025
Director
Sold on a plan
100
$71.71
$7.17K
Jeffrey William Henderson
28 Apr 2025
Director
Sold on a plan
200
$61.00
$12.20K
Jeffrey William Henderson
28 Apr 2025
Director
Sold on a plan
4,297
$60.34
$259.27K
Jeffrey William Henderson
1 Apr 2025
Director
Sold on a plan
503
$64.05
$32.22K
Jeffrey William Henderson
3 Mar 2025
Director
Sold on a plan
3,205
$59.12
$189.47K
Jeffrey William Henderson
3 Mar 2025
Director
Sold on a plan
1,795
$57.93
$103.99K
Michael J. LaBarre
27 Feb 2025
SVP, Chief Technical Officer
Sold on a plan
100
$58.74
$5.87K
Michael J. LaBarre
27 Feb 2025
SVP, Chief Technical Officer
Sold on a plan
1,597
$58.25
$93.03K
Michael J. LaBarre
26 Feb 2025
SVP, Chief Technical Officer
Sold on a plan
600
$58.65
$35.19K
Michael J. LaBarre
26 Feb 2025
SVP, Chief Technical Officer
Sold on a plan
9,400
$58.09
$546.06K
Michael J. LaBarre
25 Feb 2025
SVP, Chief Technical Officer
Sold on a plan
700
$58.67
$41.07K
Michael J. LaBarre
25 Feb 2025
SVP, Chief Technical Officer
Sold on a plan
9,300
$58.01
$539.47K
Jeffrey William Henderson
3 Feb 2025
Director
Sold on a plan
3,900
$56.41
$219.98K
Jeffrey William Henderson
3 Feb 2025
Director
Sold on a plan
1,100
$55.94
$61.54K
Jeffrey William Henderson
6 Jan 2025
Director
Sold on a plan
10,000
$50.01
$500.06K
Michael J. LaBarre
27 Feb 2024
SVP, Chief Technical Officer
Sold on a plan
10,000
$39.95
$399.46K
Showing 250 of 385 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 371
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 38
Sales straight out of an exercise 246
Sales at will 88
Transactions with no price 0
Shares from compensation/vesting 16,897,288
Sales filed before the plan box existed 81
History held since 6 Dec 2006